Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Zhejiang Hisun Pharma Invests in US-based Sagent Pharma

publication date: Feb 3, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Zhejiang Hisun Pharmaceutical Co. Ltd. revealed that it will make a $10 million investment in Sagent Pharma, a relatively new company headquartered near Chicago, Illinois. The company will purchase 7 million shares at $1.40 each in privately held Sagent, equivalent to a 4.5% stake. More details...

Stock Symbol: (SHA: 600267)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China

>>More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners